Skip to main content
Top

Drugs

Issue 4/2020

Content (11 Articles)

The Rise and Fall “ing” of the HDL Hypothesis

Julien J. Feghaly, Arshag D. Mooradian

Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs

Uazman Alam, Gordon Sloan, Solomon Tesfaye

Pharmacological Prevention of Postoperative Recurrence in Crohn’s Disease

Lucine Vuitton, Laurent Peyrin-Biroulet

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Juliette Palle, Adrien Rochand, Simon Pernot, Claire Gallois, Julien Taïeb, Aziz Zaanan

Lumateperone: First Approval

Hannah A. Blair

Lemborexant: First Approval

Lesley J. Scott

Avapritinib: First Approval

Sohita Dhillon

Sodium Oligomannate: First Approval

Yahiya Y. Syed

Correction to: Pexidartinib: First Approval

  • Open Access
  • Correction

Yvette N. Lamb

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images